| Bioactivity | Periplocymarin, a cardiac glycoside isolated from Periploca sepium and Periploca graeca, is a potential anti-cancer compound[1][2]. |
| Invitro | Periplocymarin inhibits proliferation of PC3, U937, HCT-8, Bel-7402, BGC823, A549, and A2780 cell lines in vitro with IC50 values of 0.02-0.29 µM[2]. |
| Name | Periplocymarin |
| CAS | 32476-67-8 |
| Formula | C30H46O8 |
| Molar Mass | 534.68 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
Periplocymarin
CAS: 32476-67-8 F: C30H46O8 W: 534.68
Periplocymarin, a cardiac glycoside isolated from Periploca sepium and Periploca graeca, is a potential anti-cancer comp
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.